23andMe Holding Co.

NasdaqCM:ME 株式レポート

時価総額：US$148.8m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

23andMe Holding マネジメント

マネジメント 基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Anne Wojcicki

最高経営責任者

US$7.4m

報酬総額

CEO給与比率0.9%
CEO在任期間18.7yrs
CEOの所有権19.7%
経営陣の平均在職期間2yrs
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Here's Why We're A Bit Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation

Apr 16
Here's Why We're A Bit Worried About 23andMe Holding's (NASDAQ:ME) Cash Burn Situation

Risks Still Elevated At These Prices As 23andMe Holding Co. (NASDAQ:ME) Shares Dive 26%

Mar 02
Risks Still Elevated At These Prices As 23andMe Holding Co. (NASDAQ:ME) Shares Dive 26%

We're Keeping An Eye On 23andMe Holding's (NASDAQ:ME) Cash Burn Rate

Jul 13
We're Keeping An Eye On 23andMe Holding's (NASDAQ:ME) Cash Burn Rate

23andMe Holding Co. (NASDAQ:ME) Investors Are Less Pessimistic Than Expected

Jun 15
23andMe Holding Co. (NASDAQ:ME) Investors Are Less Pessimistic Than Expected

23andMe: Disappointing Results Could Mean Potential Acquisition Target

Sep 27

23andMe: Treacherous Path To Profitability

Aug 26

23andMe drops 8% as CFO resigns

Aug 19

23andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target

Aug 11
23andMe Holding Co. (NASDAQ:ME) Just Reported, And Analysts Assigned A US$5.00 Price Target

23andMe Q1 2023 Earnings Preview

Aug 07

23andMe: Holiday Miracles Not Enough, Growth Path Too Expensive

Jun 15

23andMe: A Genetics Innovator Positioned For Growth

Feb 19

Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues

Feb 18
Need To Know: Analysts Are Much More Bullish On 23andMe Holding Co. (NASDAQ:ME) Revenues

23andMe: No Surprises With Recent Earnings, But Long-Term Story Remains Positive

Nov 21

23andMe Stock: Continued Drug-Development Progress Can Deliver Long-Term Gains

Oct 03

Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth

Sep 17
Companies Like 23andMe Holding (NASDAQ:ME) Are In A Position To Invest In Growth

23andMe: New Therapeutic Pipeline And PGS Product Growth Catalyzed By +$696M In SPAC Funding

Jul 19

CEO報酬分析

23andMe Holding の収益と比較して、Anne Wojcicki の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-US$631m

Mar 31 2024US$7mUS$65k

-US$667m

Dec 31 2023n/an/a

-US$522m

Sep 30 2023n/an/a

-US$336m

Jun 30 2023n/an/a

-US$327m

Mar 31 2023US$63kUS$63k

-US$312m

Dec 31 2022n/an/a

-US$317m

Sep 30 2022n/an/a

-US$315m

Jun 30 2022n/an/a

-US$265m

Mar 31 2022US$33mUS$59k

-US$217m

Dec 31 2021n/an/a

-US$215m

Sep 30 2021n/an/a

-US$170m

Jun 30 2021n/an/a

-US$190m

Mar 31 2021US$20mUS$55k

-US$184m

Mar 31 2020US$51kUS$51k

-US$251m

報酬と市場: Anneの 総報酬 ($USD 7.36M ) は、 US市場 ($USD 1.52M ) の同規模の企業の平均を上回っています。

報酬と収益: Anneの報酬は増加しましたが、会社は利益を上げていません。

CEO（最高経営責任者

Anne Wojcicki

18.7yrs

在職期間

US$7,363,723

報酬

Ms. Anne Wojcicki is the Co-Founder, CEO & Chair of 23andMe Inc. Ms. Anne had been a Director of Ajax I since October 30, 2020. Ms. Wojcicki serves as a General Partner of Covalence Life Sciences Partners....

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Anne Wojcicki
Co-Founder18.7yrsUS$7.36m19.71%
$ 29.3m
Joseph Selsavage
Chief Financial & Accounting Officer2yrsUS$2.13m0.085%
$ 126.6k
Eli Fry
Vice President of Operationsless than a yearデータなしデータなし
Guy Chayoun
VP, Interim General Counsel & Corporate Secretaryless than a yearデータなしデータなし
Katie Watson
Vice President of Communicationsno dataデータなしデータなし
Jonathan Ward
Chief Marketing Officer2.7yrsデータなしデータなし
Reza Afkhami
Chief Corporate Development Officer1.3yrsデータなしデータなし
Savita Pillai
Vice President of People2.1yrsデータなしデータなし
Jennifer Low
Head of Therapeutics Development6.7yrsデータなしデータなし
Kent Hillyer
Vice President of Consumer Operationsno dataデータなしデータなし
Daniel Chu
Chief Product Officer2yrsデータなしデータなし
Tracy Keim
Chief Brand Officer1.2yrsデータなしデータなし

2.0yrs

平均在職期間

55.5yo

平均年齢

経験豊富な経営陣: MEの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。